BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 6384380)

  • 1. Human vaccination studies in normal and contacts of leprosy patients.
    Samuel NM; Stanford JL; Rees RJ; Fairbairn T; Adiga RB
    Indian J Lepr; 1984; 56(1):36-47. PubMed ID: 6384380
    [No Abstract]   [Full Text] [Related]  

  • 2. Antileprosy potentials of ICRC vaccine. A study in patients and healthy volunteers.
    Deo MG; Bapat CV; Bhalerao V; Chaturvedi RM; Bhatki WS; Chulawala RG
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):540-9. PubMed ID: 6368417
    [No Abstract]   [Full Text] [Related]  

  • 3. Antileprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):27-39. PubMed ID: 10834067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leprosy vaccine--a puzzle.
    Job CK
    Lepr India; 1983 Jan; 55(1):1-7. PubMed ID: 6348409
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccination and skin test studies on the children of leprosy patients.
    Stanford JL; Stanford CA; Ghazi Saidi K; Dowlati Y; Weiss SF; Farshchi Y; Madlener F; Rees RJ
    Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):38-44. PubMed ID: 2659700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critique on the interpretation of the lepromin reaction using heat-killed M. leprae vaccine.
    Mistry NF; Antia NH
    Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):110-3. PubMed ID: 2659695
    [No Abstract]   [Full Text] [Related]  

  • 7. Animal vaccination studies with Mycobacterium leprae.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):519-23. PubMed ID: 6368416
    [No Abstract]   [Full Text] [Related]  

  • 8. Rationales for vaccines against leprosy.
    Bloom BR
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):505-9. PubMed ID: 6368414
    [No Abstract]   [Full Text] [Related]  

  • 9. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae.
    Gupte MD; Anantharaman DS; De Britto RL; Vallishayee RS; Nagaraju B; Kannan S; Sengupta U
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization studies with potential leprosy vaccine preparations in northern Malawi.
    Ponnighaus JM; Fine PE
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):25-37. PubMed ID: 3519803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Under-explored experimental topics related to integral mycobacterial vaccines for leprosy.
    Gormus BJ; Meyers WM
    Expert Rev Vaccines; 2003 Dec; 2(6):791-804. PubMed ID: 14711362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological changes observed in indeterminate and lepromatous leprosy patients and Mitsuda-negative contacts after the inoculation of a mixture of Mycobacterium leprae and BCG.
    Convit J; Aranzazu N; Pinardi M; Ulrich M
    Clin Exp Immunol; 1979 May; 36(2):214-20. PubMed ID: 383331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of lepromin positivity by a candidate anti-leprosy vaccine Mycobacterium w in lepromin negative healthy contacts of multibacillary leprosy patients.
    Kar HK; Sharma AK; Misra RS; Zaheer SA; Mukherjee A; Mukherjee R; Beena KR; Kaur H; Nair SK; Talwar GP
    Indian J Lepr; 1992; 64(4):495-500. PubMed ID: 1308525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards a vaccine against leprosy.
    Sengupta U
    Lepr India; 1981 Jan; 53(1):88-95. PubMed ID: 7012444
    [No Abstract]   [Full Text] [Related]  

  • 16. Armadillos (Dasypus novemcinctus) as a model to test antileprosy vaccines; a preliminary report.
    Job CK; Sanchez RM; Hunt R; Truman RW; Hastings RC
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):394-7. PubMed ID: 8228437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal reaction in lepromatous patients induced by a vaccine containing killed ICRC bacilli--a report of five cases.
    Bhatki WS; Chulawala RG; Bapat CV; Deo MG
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):466-72. PubMed ID: 6368413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lepromin scars in leprosy patients and persons without manifestations of the disease tested with human antigen and various concentrations of armadillo antigens (double-blind study)].
    Bechelli LM; Haddad N; Guimaraes Pagnano PM; Garrido Neves R; Melchior E; Carminatti Fregnan R
    Acta Leprol; 1979; (76-77):173-9. PubMed ID: 121832
    [No Abstract]   [Full Text] [Related]  

  • 20. An eight-year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis.
    Chaudhury S; Hazra SK; Saha B; Mazumder B; Biswas PC; Chattopadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):389-94. PubMed ID: 7963911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.